How Digital Health Technologies have been Used to Support Regulatory Drug Approval

Agathe Thierry, Antoine Manson, Hans-Peter Podhaisky

Open source

DOI
10.1007/s43441-026-01020-z
Published
2026-07-13
Container
Therapeutic Innovation & Regulatory Science
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s43441-026-01020-z,
  title = {How Digital Health Technologies have been Used to Support Regulatory Drug Approval},
  author = {Agathe Thierry and Antoine Manson and Hans-Peter Podhaisky},
  year = {2026},
  journal = {Therapeutic Innovation \& Regulatory Science},
  doi = {10.1007/s43441-026-01020-z},
  url = {https://doi.org/10.1007/s43441-026-01020-z}
}

RIS

TY  - JOUR
TI  - How Digital Health Technologies have been Used to Support Regulatory Drug Approval
AU  - Agathe Thierry
AU  - Antoine Manson
AU  - Hans-Peter Podhaisky
PY  - 2026
JO  - Therapeutic Innovation & Regulatory Science
DO  - 10.1007/s43441-026-01020-z
UR  - https://doi.org/10.1007/s43441-026-01020-z
ER  - 

APA

Thierry, A., Manson, A., & Podhaisky, H. (2026). How Digital Health Technologies have been Used to Support Regulatory Drug Approval. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-026-01020-z

Source records